Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 14/20 | 1.00 |
| ▸ | HTR2A | P28223 | 3/20 | 0.67 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.61 |
| ▸ | HTR1A | P08908 | 2/20 | 0.54 |
| ▸ | HTR1B | P28222 | 2/20 | 0.54 |
| ▸ | HTR2C | P28335 | 2/20 | 0.54 |
| ▸ | HTR1F | P30939 | 2/20 | 0.54 |
| ▸ | HTR1D | P28221 | 1/20 | 0.54 |
| ▸ | HTR7 | P34969 | 1/20 | 0.54 |
| ▸ | GABRP | O00591 | 1/20 | 0.51 |
| ▸ | GABRD | O14764 | 1/20 | 0.51 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.51 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.51 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.51 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.51 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.51 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.51 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.51 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.51 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30675329 | 1.00 | HTR6 (1.00) | HTR6HTR2ASLC6A4HTR1AHTR1B | |
| SCHEMBL1445683 | 1.00 | HTR6 (1.00) | HTR6HTR2ASLC6A4HTR1AHTR1B | |
| SCHEMBL30898 | 1.00 | HTR6 (1.00) | HTR6HTR2ASLC6A4HTR1AHTR1B | |
| SCHEMBL8790419 | 0.95 | HTR6 (0.91) | HTR6HTR2ASLC6A4HTR1AHTR1B | |
| SCHEMBL30675328 | 0.85 | HTR6 (0.74) | HTR6HTR2ASLC6A4MEN1CYP3A4 | |
| SCHEMBL24178288 | 0.82 | HTR6 (0.69) | HTR6HTR2ASLC6A4HTR1BHTR2C | |
| SCHEMBL24178316 | 0.82 | HTR6 (0.69) | HTR6HTR2ASLC6A4HTR1BHTR2C | |
| SCHEMBL30361714 | 0.82 | HTR6 (0.69) | HTR6HTR2ASLC6A4HTR1BHTR2C | |
| SCHEMBL12244120 | 0.81 | HTR6 (0.68) | HTR6HTR2AHTR1AHTR1BHTR2C | |
| SCHEMBL23802829 | 0.81 | HTR6 (0.68) | HTR6HTR2ASLC6A4HTR1BHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240383850-A1 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | MINDSET PHARMA INC. (CA) | 2024-11-21 | — | — | US | disclosed |
| WO-2023019367-A1 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | MINDSET PHARMA INC. (CA) | 2023-02-23 | — | — | WO | disclosed |
| WO-2023019367-A1 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | MINDSET PHARMA INC. (CA) | 2023-02-23 | — | — | WO | disclosed |
| US-20130231373-A1 | HYDROXAMATE-BASED INHIBITORS OF DEACETYLASES | NOVARTIS AG (CH) | 2013-09-05 | — | — | US | disclosed |
| WO-2012025164-A1 | HYDROXAMATE-BASED INHIBITORS OF DEACETYLASES | NOVARTIS AG (CH) | 2012-03-01 | — | — | WO | disclosed |
| US-6465500-B1 | PSYCHOTHERAPEUTICS; DEPRESSION, ANXIETY, EATING DISORDERS, OBESITY, DRUG ABUSE, CLUSTER HEADACHE, MIGRAINE, PAIN, CHRONIC PAROXYSMAL HEMICRANIA, HEADACHE ASSOCIATED WITH VASCULAR DISORDERS; ANTIHYPERTENSIVES, VASODILATORS | PFIZER INC. | 2002-10-15 | — | — | US | disclosed |
| US-6436957-B1 | DISORDERS FROM DEFICIENT SEROTONERGIC NEUROTRANSMISSION; 3-PYRROLIDIN-2-YLMETHYL-1H-INDOLES | PFIZER INC. | 2002-08-20 | — | — | US | disclosed |
| US-6410739-B1 | CENTRAL NERVOUS SYSTEM DISORDERS | PFIZER INC | 2002-06-25 | — | — | US | disclosed |
| US-6387937-B1 | ANTISEROTONINE AGENT; HEADACHES | PFIZER INC. | 2002-05-14 | — | — | US | disclosed |
| US-6387941-B1 | ANTISEROTONINE AGENTS | PFIZER INC. | 2002-05-14 | — | — | US | disclosed |
| US-5747501-A | Indole derivatives | PFIZER, INC. (US) | 1998-05-05 | — | — | US | disclosed |
| EP-0592438-B1 | INDOLE DERIVATIVES | PFIZER (US) | 1997-08-27 | — | — | EP | disclosed |
| US-5607951-A | SEROTONIN AGONIST FOR NERVOUS SYSTEM DISORDERS, ANALGESICS AND PSYCHOTHERAPEUTICS | PFIZER INC (US) | 1997-03-04 | — | — | US | disclosed |
| US-5578612-A | Indole derivatives | PFIZER INC. (US) | 1996-11-26 | — | — | US | disclosed |
| US-5559246-A | PROCESS OF DEHYDROHALOGENATION FOR CYCLIZATION TO PRODUCE PSYCHOTHERAPEUTIC AGENTS AND ANTISEROTONIN ANTAGONIST | PFIZER INC. (US) | 1996-09-24 | — | — | US | disclosed |
| US-5559129-A | SEROTONIN (5HT1) ANTAGONIST FOR TREATMENT OF DEPRESSION, ANXIETY, EATING DISORDERS, OBESITY, DRUG ABUSE, HEADACHES, AND PAIN | PFIZER INC (US) | 1996-09-24 | — | — | US | disclosed |
| US-5545644-A | SEROTONIN AGONISTS; HYPOTENSIVE AND ANXIOLYTIC AGENTS; ANALGESICS; ANTIDEPRESSANTS; EATING DISORDERS; DRUG ABUSE; HEADACHES; VASCULAR DISORDERS | PFIZER INC. (US) | 1996-08-13 | — | — | US | disclosed |
| EP-0635017-A1 | INDOLE DERIVATIVES AS 5-HT1 AGONISTS | PFIZER INC. (US) | 1995-01-25 | — | — | EP | disclosed |
| WO-1993020073-A1 | INDOLE DERIVATIVES AS 5-HT1 AGONISTS | PFIZER INC. (US) | 1993-10-14 | — | — | WO | disclosed |
| WO-1992006973-A1 | INDOLE DERIVATIVES | PFIZER INC. (US) | 1992-04-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130231373-A1 | HYDROXAMATE-BASED INHIBITORS OF DEACETYLASES | HDAC1, HDAC11, HDAC3 | HTR6 2080/4885HTR2A 2046/4885SLC6A4 2277/4885 |
| US-20240383850-A1 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | TPH1, HTR5A, TPH2 | HTR6 6/4885HTR2A 7/4885SLC6A4 18/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.